James Rothman

James Rothman has an estimated net worth of $12 Million. This is based on reported shares across multiple companies, which include Adhera Therapeutics, Inc., ACA Capital Holdings Inc, Bruker Cellular Analysis, Inc., and INTROGEN THERAPEUTICS INC.

2008 was James Rothman's most active year for acquiring shares with 6 total transactions. James Rothman's most active month to acquire stocks was the month of July. 2021 was James Rothman's most active year for disposing of shares, totalling 8 transactions. James Rothman's most active month to dispose stocks was the month of February. 2020 saw James Rothman paying a total of $947,500.00 for 375,000 shares, this is the most they've acquired in one year. In 2021 James Rothman cashed out on 236,155 shares for a total of $13,020,371.72, their largest year based on trade value.